{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:57:21Z","timestamp":1786978641150,"version":"build-2736575974"},"publisher-location":"Berlin, Heidelberg","reference-count":195,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/82_2025_303","type":"book-chapter","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T08:51:52Z","timestamp":1748335912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gastric Carcinoma"],"prefix":"10.1007","author":[{"given":"Young-Sik","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"303_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00428-012-1303-2","volume":"461","author":"H Abe","year":"2012","unstructured":"Abe H, Maeda D, Hino R, Otake Y, Isogai M, Ushiku AS, Matsusaka K, Kunita A, Ushiku T, Uozaki H, Tateishi Y, Hishima T, Iwasaki Y, Ishikawa S, Fukayama M (2012) ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein\u2013Barr virus infection and microsatellite instability. Virchows Arch 461:367\u2013377. https:\/\/doi.org\/10.1007\/s00428-012-1303-2","journal-title":"Virchows Arch"},{"key":"303_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000434683","volume":"82","author":"H Abe","year":"2015","unstructured":"Abe H, Kaneda A, Fukayama M (2015) Epstein-Barr virus-associated gastric carcinoma: use of host cell machineries and somatic gene mutations. Pathobiology 82:212\u2013223. https:\/\/doi.org\/10.1159\/000434683","journal-title":"Pathobiology"},{"key":"303_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256440","volume":"16","author":"H Abe","year":"2021","unstructured":"Abe H, Kunita A, Otake Y, Kanda T, Kaneda A, Ushiku T, Fukayama M (2021) Virus\u2013host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: potential roles of lost ARID1A expression in its early stage. PLoS One 16:e0256440. https:\/\/doi.org\/10.1371\/journal.pone.0256440","journal-title":"PLoS One"},{"key":"303_CR4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1128\/jvi.01528-10","volume":"85","author":"R Amoroso","year":"2011","unstructured":"Amoroso R, Fitzsimmons L, Thomas WA, Kelly GL, Rowe M, Bell AI (2011) Quantitative studies of Epstein-Barr virus-encoded MicroRNAs provide novel insights into their regulation. J Virol 85:996\u20131010. https:\/\/doi.org\/10.1128\/jvi.01528-10","journal-title":"J Virol"},{"key":"303_CR5","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-21-2390","volume":"28","author":"LP Andrews","year":"2022","unstructured":"Andrews LP, Cillo AR, Karapetyan L, Kirkwood JM, Workman CJ, Vignali DAA (2022) Molecular pathways and mechanisms of LAG3 in cancer therapy. Clin Cancer Res 28:5030\u20135039. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2390","journal-title":"Clin Cancer Res"},{"key":"303_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1440-1827.1997.tb04509.x","volume":"47","author":"J Arikawa","year":"1997","unstructured":"Arikawa J, Tokunaga M, Satoh E, Tanaka S, Land CE (1997) Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: a case-control study. Pathol Int 47:360\u2013367. https:\/\/doi.org\/10.1111\/j.1440-1827.1997.tb04509.x","journal-title":"Pathol Int"},{"key":"303_CR7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1517\/13543784.2011.566863","volume":"20","author":"Y Asaoka","year":"2011","unstructured":"Asaoka Y, Ikenoue T, Koike K (2011) New targeted therapies for gastric cancer. Expert Opin Investig Drugs 20:595","journal-title":"Expert Opin Investig Drugs"},{"key":"303_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004080","volume":"10","author":"Y Bai","year":"2022","unstructured":"Bai Y, Xie T, Wang Z, Tong S, Zhao X, Zhao F, Cai J, Wei X, Peng Z, Shen L (2022) Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer. J Immunother Cancer 10:e004080. https:\/\/doi.org\/10.1136\/jitc-2021-004080","journal-title":"J Immunother Cancer"},{"key":"303_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrc.2017.58","volume":"17","author":"T Baslan","year":"2017","unstructured":"Baslan T, Hicks J (2017) Unravelling biology and shifting paradigms in cancer with single-cell sequencing. Nat Rev Cancer 17:557\u2013569. https:\/\/doi.org\/10.1038\/nrc.2017.58","journal-title":"Nat Rev Cancer"},{"issue":"7517","key":"303_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"AJ Bass","year":"2014","unstructured":"Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, Hinoue T, Laird PW, Curtis C, Shen H, Weisenberger DJ, Schultz N, Shen R, Weinhold N, Kelsen DP, Bowlby R, Chu A, Kasaian K, Mungall AJ et al (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202\u2013209. https:\/\/doi.org\/10.1038\/nature13480","journal-title":"Nature"},{"key":"303_CR11","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3748\/wjg.v12.i21.3297","volume":"12","author":"J Becker","year":"2006","unstructured":"Becker J, M\u00fcller-Tidow C, Serve H, Domschke W, Pohle T (2006) Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy. World J Gastroenterol 12:3297\u20133305. https:\/\/doi.org\/10.3748\/wjg.v12.i21.3297","journal-title":"World J Gastroenterol"},{"key":"303_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nm.3799","volume":"21","author":"BG Bitler","year":"2015","unstructured":"Bitler BG, Aird KM, Garipov A, Li H, Amatangelo M, Kossenkov AV, Schultz DC, Liu Q, Shih I-M, Conejo-Garcia JR, Speicher DW, Zhang R (2015) Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nat Med 21:231\u2013238. https:\/\/doi.org\/10.1038\/nm.3799","journal-title":"Nat Med"},{"key":"303_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1261\/rna.5167604","volume":"10","author":"MT Bohnsack","year":"2004","unstructured":"Bohnsack MT, Czaplinski K, G\u00f6rlich D (2004) Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10:185\u2013191. https:\/\/doi.org\/10.1261\/rna.5167604","journal-title":"RNA"},{"key":"303_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163548","volume":"133","author":"A Bonifacius","year":"2023","unstructured":"Bonifacius A, Lamottke B, Tischer-Zimmermann S, Schultze-Florey R, Goudeva L, Heuft H-G, Arseniev L, Beier R, Beutel G, Cario G, Fr\u00f6hlich B, Greil J, Hansmann L, Hasenkamp J, H\u00f6fs M, Hundsdoerfer P, Jost E, Kafa K, Kriege O, Kr\u00f6ger N, Mathas S, Meisel R, Nathrath M, Putkonen M, Ravens S, Reinhardt HC, Sala E, Sauer MG, Schmitt C, Schroers R, Steckel NK, Trappe RU, Verbeek M, Wolff D, Blasczyk R, Eiz-Vesper B, Maecker-Kolhoff B (2023) Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors. J Clin Invest 133:e163548. https:\/\/doi.org\/10.1172\/JCI163548","journal-title":"J Clin Invest"},{"key":"303_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102737","volume":"127","author":"J Bos","year":"2024","unstructured":"Bos J, Groen-van Schooten TS, Brugman CP, Jamaludin FS, van Laarhoven HWM, Derks S (2024) The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: a systematic review. Cancer Treat Rev 127:102737. https:\/\/doi.org\/10.1016\/j.ctrv.2024.102737","journal-title":"Cancer Treat Rev"},{"key":"303_CR16","doi-asserted-by":"publisher","first-page":"7069242","DOI":"10.1155\/2017\/7069242","volume":"2017","author":"MG C\u00e1rdenas-Mondrag\u00f3n","year":"2017","unstructured":"C\u00e1rdenas-Mondrag\u00f3n MG, Torres J, S\u00e1nchez-Zauco N, G\u00f3mez-Delgado A, Camorlinga-Ponce M, Maldonado-Bernal C, Fuentes-Panan\u00e1 EM (2017) Elevated levels of interferon-\u03b3 are associated with high levels of Epstein-Barr virus reactivation in patients with the intestinal type of gastric cancer. J Immunol Res 2017:7069242. https:\/\/doi.org\/10.1155\/2017\/7069242","journal-title":"J Immunol Res"},{"key":"303_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbcan.2018.07.005","volume":"1870","author":"JJ Caumanns","year":"2018","unstructured":"Caumanns JJ, Wisman GBA, Berns K, van der Zee AGJ, de Jong S (2018) ARID1A mutant ovarian clear cell carcinoma: a clear target for synthetic lethal strategies. Biochim Biophys Acta Rev Cancer 1870:176\u2013184. https:\/\/doi.org\/10.1016\/j.bbcan.2018.07.005","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"303_CR18","doi-asserted-by":"publisher","unstructured":"Chakravorty S, Afzali B, Kazemian M (2022) EBV-associated diseases: current therapeutics and emerging technologies. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.1059133","DOI":"10.3389\/fimmu.2022.1059133"},{"key":"303_CR19","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1158\/1078-0432.CCR-05-1601","volume":"12","author":"M-S Chang","year":"2006","unstructured":"Chang M-S, Uozaki H, Chong J-M, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua R, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M (2006) CpG Island Methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res 12:2995\u20133002. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1601","journal-title":"Clin Cancer Res"},{"key":"303_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1046\/j.1365-2559.2000.00843.x","volume":"36","author":"F Chapel","year":"2000","unstructured":"Chapel F et al (2000) Epstein\u2013Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours. Histopathology 36:252\u2013261. https:\/\/doi.org\/10.1046\/j.1365-2559.2000.00843.x","journal-title":"Histopathology"},{"key":"303_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5501\/wjv.v1.i6.154","volume":"1","author":"J Chen","year":"2012","unstructured":"Chen J (2012) Roles of the PI3K\/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications. World J Virol 1:154. https:\/\/doi.org\/10.5501\/wjv.v1.i6.154","journal-title":"World J Virol"},{"key":"303_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/femsre\/fuz023","volume":"43","author":"J Chen","year":"2019","unstructured":"Chen J, Longnecker R (2019) Epithelial cell infection by Epstein\u2013Barr virus. FEMS Microbiol Rev 43:674\u2013683. https:\/\/doi.org\/10.1093\/femsre\/fuz023","journal-title":"FEMS Microbiol Rev"},{"key":"303_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.virusres.2011.06.011","volume":"160","author":"J Chen","year":"2011","unstructured":"Chen J, Jiang Y, Li H, Ding Y, Fan X, Xiao L, Han J, Du H, Shao C (2011) Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma. Virus Res 160:191\u2013199. https:\/\/doi.org\/10.1016\/j.virusres.2011.06.011","journal-title":"Virus Res"},{"key":"303_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","volume":"3","author":"J Chen","year":"2018","unstructured":"Chen J, Sathiyamoorthy K, Zhang X, Schaller S, Perez White BE, Jardetzky TS, Longnecker R (2018) Ephrin receptor A2 is a functional entry receptor for Epstein\u2013Barr virus. Nat Microbiol 3:172\u2013180. https:\/\/doi.org\/10.1038\/s41564-017-0081-7","journal-title":"Nat Microbiol"},{"key":"303_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13073-021-00963-2","volume":"13","author":"Z-H Chen","year":"2021","unstructured":"Chen Z-H, Yan S-M, Chen X-X, Zhang Q, Liu S-X, Liu Y, Luo Y-L, Zhang C, Xu M, Zhao Y-F, Huang L-Y, Liu B-L, Xia T-L, Xu D-Z, Liang Y, Chen Y-M, Wang W, Yuan S-Q, Zhang H-Z, Yun J-P, Zhai W-W, Zeng M-S, Bai F, Zhong Q (2021) The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma. Genome Med 13:146. https:\/\/doi.org\/10.1186\/s13073-021-00963-2","journal-title":"Genome Med"},{"key":"303_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/or.2021.8224","volume":"47","author":"W Chen","year":"2022","unstructured":"Chen W, Xie Y, Wang T, Wang L (2022) New insights into Epstein-Barr virus-associated tumors: exosomes. Oncol Rep 47:13. https:\/\/doi.org\/10.3892\/or.2021.8224","journal-title":"Oncol Rep"},{"key":"303_CR27","doi-asserted-by":"publisher","first-page":"13214","DOI":"10.1128\/jvi.05580-11","volume":"85","author":"LS Chesnokova","year":"2011","unstructured":"Chesnokova LS, Hutt-Fletcher LM (2011) Fusion of Epstein-Barr virus with epithelial cells can be triggered by \u03b1v\u03b25 in addition to \u03b1v\u03b26 and \u03b1v\u03b28, and integrin binding triggers a conformational change in glycoproteins gHgL. J Virol 85:13214\u201313223. https:\/\/doi.org\/10.1128\/jvi.05580-11","journal-title":"J Virol"},{"key":"303_CR28","doi-asserted-by":"publisher","first-page":"20464","DOI":"10.1073\/pnas.0907508106","volume":"106","author":"LS Chesnokova","year":"2009","unstructured":"Chesnokova LS, Nishimura SL, Hutt-Fletcher LM (2009) Fusion of epithelial cells by Epstein\u2013Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins \u03b1v\u03b26 or \u03b1v\u03b28. Proc Natl Acad Sci 106:20464\u201320469. https:\/\/doi.org\/10.1073\/pnas.0907508106","journal-title":"Proc Natl Acad Sci"},{"key":"303_CR29","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/jclinpath-2012-201067","volume":"65","author":"R Chetty","year":"2012","unstructured":"Chetty R (2012) Gastrointestinal cancers accompanied by a dense lymphoid component: an overview with special reference to gastric and colonic medullary and lymphoepithelioma-like carcinomas. J Clin Pathol 65:1062\u20131065. https:\/\/doi.org\/10.1136\/jclinpath-2012-201067","journal-title":"J Clin Pathol"},{"key":"303_CR30","doi-asserted-by":"publisher","unstructured":"Cho J, Chang YH, Heo YJ, Kim S, Kim NKD, Park JO, Kang WK, Lee J, Kim K-M (2018) Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability. ESMO Open 3. https:\/\/doi.org\/10.1136\/esmoopen-2018-000326","DOI":"10.1136\/esmoopen-2018-000326"},{"key":"303_CR31","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1128\/jvi.03159-12","volume":"87","author":"H Choi","year":"2013","unstructured":"Choi H, Lee H, Kim SR, Gho YS, Lee SK (2013) Epstein-Barr virus-encoded MicroRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol 87:8135\u20138144. https:\/\/doi.org\/10.1128\/jvi.03159-12","journal-title":"J Virol"},{"key":"303_CR32","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/genes15081036","volume":"15","author":"AJ Clark","year":"2024","unstructured":"Clark AJ, Lillard JW (2024) A comprehensive review of bioinformatics tools for genomic biomarker discovery driving precision oncology. Genes 15:1036. https:\/\/doi.org\/10.3390\/genes15081036","journal-title":"Genes"},{"key":"303_CR33","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1634\/theoncologist.2020-0037","volume":"25","author":"S Corallo","year":"2020","unstructured":"Corallo S, Fuc\u00e0 G, Morano F, Salati M, Spallanzani A, Gloghini A, Volpi CC, Trupia DV, Lobefaro R, Guarini V, Milione M, Cattaneo L, Antista M, Prisciandaro M, Raimondi A, Sposito C, Mazzaferro V, de Braud F, Pietrantonio F, Di Bartolomeo M (2020) Clinical behavior and treatment response of Epstein-Barr virus-positive metastatic gastric cancer: implications for the development of future trials. Oncologist 25:780\u2013786. https:\/\/doi.org\/10.1634\/theoncologist.2020-0037","journal-title":"Oncologist"},{"key":"303_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.critrevonc.2018.10.007","volume":"133","author":"C Coutzac","year":"2019","unstructured":"Coutzac C, Pernot S, Chaput N, Zaanan A (2019) Immunotherapy in advanced gastric cancer, is it the future? Crit Rev Oncol Hematol 133:25\u201332. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.10.007","journal-title":"Crit Rev Oncol Hematol"},{"key":"303_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000787","volume":"6","author":"BR Cullen","year":"2010","unstructured":"Cullen BR (2010) Five questions about viruses and MicroRNAs. PLoS Pathog 6:e1000787. https:\/\/doi.org\/10.1371\/journal.ppat.1000787","journal-title":"PLoS Pathog"},{"key":"303_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13027-020-00307-6","volume":"15","author":"V De Re","year":"2020","unstructured":"De Re V, Caggiari L, De Zorzi M, Fanotto V, Miolo G, Puglisi F, Cannizzaro R, Canzonieri V, Steffan A, Farruggia P, Lopci E, d\u2019Amore ESG, Burnelli R, Mussolin L, Mascarin M (2020) Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer. Infect Agents Cancer 15:42. https:\/\/doi.org\/10.1186\/s13027-020-00307-6","journal-title":"Infect Agents Cancer"},{"key":"303_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/cac2.12529","volume":"44","author":"C Deng","year":"2024","unstructured":"Deng C (2024) Revealing the secret behind Epstein-Barr virus-specific tumor immune contexture. Cancer Commun (Lond) 44:491\u2013494. https:\/\/doi.org\/10.1002\/cac2.12529","journal-title":"Cancer Commun (Lond)"},{"key":"303_CR38","doi-asserted-by":"publisher","first-page":"32925","DOI":"10.18632\/oncotarget.9076","volume":"7","author":"S Derks","year":"2016","unstructured":"Derks S, Liao X, Chiaravalli AM, Xu X, Camargo MC, Solcia E, Sessa F, Fleitas T, Freeman GJ, Rodig SJ, Rabkin CS, Bass AJ (2016) Abundant PD-L1 expression in Epstein-Barr virus-infected gastric cancers. Oncotarget 7:32925\u201332932. https:\/\/doi.org\/10.18632\/oncotarget.9076","journal-title":"Oncotarget"},{"key":"303_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biochi.2023.07.010","volume":"214","author":"V-T Dinh","year":"2023","unstructured":"Dinh V-T, Loa\u00ebc N, Quill\u00e9v\u00e9r\u00e9 A, Le S\u00e9n\u00e9chal R, Keruzor\u00e9 M, Martins RP, Granzhan A, Blondel M (2023) The hide-and-seek game of the oncogenic Epstein-Barr virus-encoded EBNA1 protein with the immune system: an RNA G-quadruplex tale. Biochimie 214:57\u201368. https:\/\/doi.org\/10.1016\/j.biochi.2023.07.010","journal-title":"Biochimie"},{"key":"303_CR40","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/cr.2007.67","volume":"17","author":"T Du","year":"2007","unstructured":"Du T, Zamore PD (2007) Beginning to understand microRNA function. Cell Res 17:661\u2013663. https:\/\/doi.org\/10.1038\/cr.2007.67","journal-title":"Cell Res"},{"key":"303_CR41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"283","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 283:702\u2013703. https:\/\/doi.org\/10.1016\/S0140-6736(64)91524-7","journal-title":"Lancet"},{"key":"303_CR195","doi-asserted-by":"publisher","unstructured":"Facciorusso A, Antonino M, Maso MD, Muscatiello N (2014) Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: A meta-analysis. World Journal of Gastrointestinal Endoscopy 6:555\u2013563. https:\/\/doi.org\/10.4253\/wjge.v6.i11.555","DOI":"10.4253\/wjge.v6.i11.555"},{"key":"303_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001294","volume":"7","author":"R Feederle","year":"2011","unstructured":"Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, Cullen BR, Delecluse H-J (2011) A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 7:e1001294. https:\/\/doi.org\/10.1371\/journal.ppat.1001294","journal-title":"PLoS Pathog"},{"key":"303_CR43","doi-asserted-by":"publisher","first-page":"26318","DOI":"10.1073\/pnas.2007946117","volume":"117","author":"K Fish","year":"2020","unstructured":"Fish K, Comoglio F, Shaffer AL, Ji Y, Pan K-T, Scheich S, Oellerich A, Doebele C, Ikeda M, Schaller SJ, Nguyen H, Muppidi J, Wright GW, Urlaub H, Serve H, Staudt LM, Longnecker R, Oellerich T (2020) Rewiring of B cell receptor signaling by Epstein\u2013Barr virus LMP2A. Proc Natl Acad Sci 117:26318\u201326327. https:\/\/doi.org\/10.1073\/pnas.2007946117","journal-title":"Proc Natl Acad Sci"},{"key":"303_CR44","first-page":"1090","volume":"59","author":"AS Fleisher","year":"1999","unstructured":"Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou T-T, Abraham JM, Kong D, Smolinski KN, Shi Y-Q, Rhyu M-G, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ (1999) Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability1. Cancer Res 59:1090\u20131095","journal-title":"Cancer Res"},{"key":"303_CR45","doi-asserted-by":"publisher","DOI":"10.6064\/2012\/438204","volume":"2012","author":"L Frappier","year":"2012","unstructured":"Frappier L (2012) The Epstein-Barr virus EBNA1 protein. Scientifica (Cairo) 2012:438204. https:\/\/doi.org\/10.6064\/2012\/438204","journal-title":"Scientifica (Cairo)"},{"key":"303_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-019-1001-7","volume":"18","author":"M Fu","year":"2019","unstructured":"Fu M, Gu J, Jiang P, Qian H, Xu W, Zhang X (2019) Exosomes in gastric cancer: roles, mechanisms, and applications. Mol Cancer 18:41. https:\/\/doi.org\/10.1186\/s12943-019-1001-7","journal-title":"Mol Cancer"},{"key":"303_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1440-1827.2010.02533.x","volume":"60","author":"M Fukayama","year":"2010","unstructured":"Fukayama M (2010) Epstein-Barr virus and gastric carcinoma. Pathol Int 60:337\u2013350. https:\/\/doi.org\/10.1111\/j.1440-1827.2010.02533.x","journal-title":"Pathol Int"},{"key":"303_CR48","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.prp.2011.07.004","volume":"207","author":"M Fukayama","year":"2011","unstructured":"Fukayama M, Ushiku T (2011) Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract 207:529\u2013537. https:\/\/doi.org\/10.1016\/j.prp.2011.07.004","journal-title":"Pathol Res Pract"},{"key":"303_CR49","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s101200050003","volume":"1","author":"M Fukayama","year":"1998","unstructured":"Fukayama M, Chong J-M, Kaizaki Y (1998) Epstein-Barr virus and gastric carcinoma. Gastric Cancer 1:104\u2013114. https:\/\/doi.org\/10.1007\/s101200050003","journal-title":"Gastric Cancer"},{"key":"303_CR50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/978-981-10-7230-7_20","volume":"1045","author":"M Fukayama","year":"2018","unstructured":"Fukayama M, Kunita A, Kaneda A (2018) Gastritis-infection-cancer sequence of Epstein-Barr virus-associated gastric cancer. Adv Exp Med Biol 1045:437\u2013457","journal-title":"Adv Exp Med Biol"},{"key":"303_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00428-019-02724-4","volume":"476","author":"M Fukayama","year":"2020","unstructured":"Fukayama M, Abe H, Kunita A, Shinozaki-Ushiku A, Matsusaka K, Ushiku T, Kaneda A (2020) Thirty years of Epstein-Barr virus-associated gastric carcinoma. Virchows Arch 476:353\u2013365. https:\/\/doi.org\/10.1007\/s00428-019-02724-4","journal-title":"Virchows Arch"},{"key":"303_CR52","doi-asserted-by":"publisher","first-page":"55265","DOI":"10.18632\/oncotarget.19423","volume":"8","author":"S Funata","year":"2017","unstructured":"Funata S, Matsusaka K, Yamanaka R, Yamamoto S, Okabe A, Fukuyo M, Aburatani H, Fukayama M, Kaneda A (2017) Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein-Barr virus infection. Oncotarget 8:55265\u201355279. https:\/\/doi.org\/10.18632\/oncotarget.19423","journal-title":"Oncotarget"},{"key":"303_CR53","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-019-0743-4","volume":"12","author":"P Gao","year":"2019","unstructured":"Gao P, Lazare C, Cao C, Meng Y, Wu P, Zhi W, Lin S, Wei J, Huang X, Xi L, Chen G, Hu J, Ma D, Wu P (2019) Immune checkpoint inhibitors in the treatment of virus-associated cancers. J Hematol Oncol 12:58. https:\/\/doi.org\/10.1186\/s13045-019-0743-4","journal-title":"J Hematol Oncol"},{"key":"303_CR54","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1002\/jcp.27220","volume":"234","author":"E Ghadami","year":"2019","unstructured":"Ghadami E, Nikbakhsh N, Fattahi S, Kosari-Monfared M, Ranaee M, Taheri H, Amjadi-Moheb F, Godazandeh G, Shafaei S, Nosrati A, Pilehchian Langroudi M, Samadani AA, Amirbozorgi G, Mirnia V, Akhavan-Niaki H (2019) Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: a footprint of infections. J Cell Physiol 234:4115\u20134124. https:\/\/doi.org\/10.1002\/jcp.27220","journal-title":"J Cell Physiol"},{"key":"303_CR55","doi-asserted-by":"publisher","first-page":"14786","DOI":"10.1038\/s41598-020-71775-4","volume":"10","author":"F Ghasemi","year":"2020","unstructured":"Ghasemi F, Tessier TM, Gameiro SF, Maciver AH, Cecchini MJ, Mymryk JS (2020) High MHC-II expression in Epstein\u2013Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation. Sci Rep 10:14786. https:\/\/doi.org\/10.1038\/s41598-020-71775-4","journal-title":"Sci Rep"},{"key":"303_CR56","doi-asserted-by":"publisher","first-page":"6021934","DOI":"10.1155\/2016\/6021934","volume":"2016","author":"A Giudice","year":"2016","unstructured":"Giudice A, D\u2019Arena G, Crispo A, Tecce MF, Nocerino F, Grimaldi M, Rotondo E, D\u2019Ursi AM, Scrima M, Galdiero M, Ciliberto G, Capunzo M, Franci G, Barbieri A, Bimonte S, Montella M (2016) Role of viral miRNAs and epigenetic modifications in Epstein-Barr virus-associated gastric carcinogenesis. Oxidative Med Cell Longev 2016:6021934. https:\/\/doi.org\/10.1155\/2016\/6021934","journal-title":"Oxidative Med Cell Longev"},{"key":"303_CR57","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/ajcp\/aqx096","volume":"148","author":"RS Gonzalez","year":"2017","unstructured":"Gonzalez RS, Cates JMM, Revetta F, McMahon LA, Washington K (2017) Gastric carcinomas with lymphoid stroma: categorization and comparison with solid-type colonic carcinomas. Am J Clin Pathol 148:477\u2013484. https:\/\/doi.org\/10.1093\/ajcp\/aqx096","journal-title":"Am J Clin Pathol"},{"key":"303_CR58","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaoncol.2018.1701","volume":"4","author":"AM Goodman","year":"2018","unstructured":"Goodman AM, Piccioni D, Kato S, Boichard A, Wang H-Y, Frampton G, Lippman SM, Connelly C, Fabrizio D, Miller V, Sicklick JK, Kurzrock R (2018) Prevalence of PDL1 amplification and preliminary response to immune checkpoint blockade in solid tumors. JAMA Oncol 4:1237\u20131244. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1701","journal-title":"JAMA Oncol"},{"key":"303_CR59","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1038\/emm.2014.93","volume":"47","author":"ML Gulley","year":"2015","unstructured":"Gulley ML (2015) Genomic assays for Epstein\u2013Barr virus-positive gastric adenocarcinoma. Exp Mol Med 47:e134. https:\/\/doi.org\/10.1038\/emm.2014.93","journal-title":"Exp Mol Med"},{"key":"303_CR60","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3390\/ijms19072079","volume":"19","author":"I Gullo","year":"2018","unstructured":"Gullo I, Carvalho J, Martins D, Lemos D, Monteiro AR, Ferreira M, Das K, Tan P, Oliveira C, Carneiro F, Oliveira P (2018) The transcriptomic landscape of gastric cancer: insights into Epstein-Barr virus infected and microsatellite unstable tumors. Int J Mol Sci 19:2079. https:\/\/doi.org\/10.3390\/ijms19072079","journal-title":"Int J Mol Sci"},{"key":"303_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2559.1994.tb01565.x","volume":"25","author":"SJ Hamilton-Dutoit","year":"1994","unstructured":"Hamilton-Dutoit SJ, Pallesen G (1994) Detection of Epstein\u2013Barr virus small RNAs in routine paraffin sections using non-isotopic RNA\/RNA in situ hybridization. Histopathology 25:101\u2013111. https:\/\/doi.org\/10.1111\/j.1365-2559.1994.tb01565.x","journal-title":"Histopathology"},{"key":"303_CR62","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12032-015-0525-y","volume":"32","author":"D He","year":"2015","unstructured":"He D, Zhang Y, Zhang N, Zhou L, Chen J, Jiang Y, Shao C (2015) Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein\u2013Barr virus-associated gastric carcinomas. Med Oncol 32:92. https:\/\/doi.org\/10.1007\/s12032-015-0525-y","journal-title":"Med Oncol"},{"key":"303_CR63","doi-asserted-by":"publisher","first-page":"e2353","DOI":"10.1038\/cddis.2016.253","volume":"7","author":"B He","year":"2016","unstructured":"He B, Li W, Wu Y, Wei F, Gong Z, Bo H, Wang Y, Li X, Xiang B, Guo C, Liao Q, Chen P, Zu X, Zhou M, Ma J, Li X, Li Y, Li G, Xiong W, Zeng Z (2016) Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death Dis 7:e2353\u2013e2353. https:\/\/doi.org\/10.1038\/cddis.2016.253","journal-title":"Cell Death Dis"},{"key":"303_CR64","doi-asserted-by":"publisher","first-page":"706","DOI":"10.5858\/2008-132-706-EVLGC","volume":"132","author":"CHP Herath","year":"2008","unstructured":"Herath CHP, Chetty R (2008) Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma. Arch Pathol Lab Med 132:706\u2013709. https:\/\/doi.org\/10.5858\/2008-132-706-EVLGC","journal-title":"Arch Pathol Lab Med"},{"key":"303_CR65","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.3390\/microorganisms8111776","volume":"8","author":"M Hinata","year":"2020","unstructured":"Hinata M, Kunita A, Abe H, Morishita Y, Sakuma K, Yamashita H, Seto Y, Ushiku T, Fukayama M (2020) Exosomes of Epstein-Barr virus-associated gastric carcinoma suppress dendritic cell maturation. Microorganisms 8:1776. https:\/\/doi.org\/10.3390\/microorganisms8111776","journal-title":"Microorganisms"},{"key":"303_CR66","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1158\/0008-5472.CAN-07-3027","volume":"68","author":"R Hino","year":"2008","unstructured":"Hino R, Uozaki H, Inoue Y, Shintani Y, Ushiku T, Sakatani T, Takada K, Fukayama M (2008) Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Cancer Res 68:1427\u20131435. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-3027","journal-title":"Cancer Res"},{"key":"303_CR67","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1158\/0008-5472.CAN-08-3070","volume":"69","author":"R Hino","year":"2009","unstructured":"Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K, Fukayama M (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 69:2766\u20132774. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3070","journal-title":"Cancer Res"},{"key":"303_CR68","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.canlet.2020.01.001","volume":"473","author":"G Hu","year":"2020","unstructured":"Hu G, Tu W, Yang L, Peng G, Yang L (2020) ARID1A deficiency and immune checkpoint blockade therapy: from mechanisms to clinical application. Cancer Lett 473:148\u2013155. https:\/\/doi.org\/10.1016\/j.canlet.2020.01.001","journal-title":"Cancer Lett"},{"key":"303_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00771-5","volume":"7","author":"B Huang","year":"2022","unstructured":"Huang B, Li Q, Geng Q, Lao J, Guo J, Huang S, Xu D (2022) ASTE1 frameshift mutation triggers the immune response in Epstein-Barr virus-associated gastric cancer. Sig Transduct Target Ther 7:1\u20133. https:\/\/doi.org\/10.1038\/s41392-021-00771-5","journal-title":"Sig Transduct Target Ther"},{"key":"303_CR70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ijc.29698","volume":"138","author":"KF Hui","year":"2016","unstructured":"Hui KF, Cheung AKL, Choi CK, Yeung PL, Middeldorp JM, Lung ML, Tsao SW, Chiang AKS (2016) Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir. Int J Cancer 138:125\u2013136. https:\/\/doi.org\/10.1002\/ijc.29698","journal-title":"Int J Cancer"},{"key":"303_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","volume":"50","author":"B Hwang","year":"2018","unstructured":"Hwang B, Lee JH, Bang D (2018) Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp Mol Med 50:1\u201314. https:\/\/doi.org\/10.1038\/s12276-018-0071-8","journal-title":"Exp Mol Med"},{"key":"303_CR72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1200\/JCO.2011.39.8495","volume":"31","author":"V Icheva","year":"2013","unstructured":"Icheva V, Kayser S, Wolff D, Tuve S, Kyzirakos C, Bethge W, Greil J, Albert MH, Schwinger W, Nathrath M, Schumm M, Stevanovic S, Handgretinger R, Lang P, Feuchtinger T (2013) Adoptive transfer of Epstein-Barr virus (EBV) nuclear antigen 1\u2013specific T cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. JCO 31:39\u201348. https:\/\/doi.org\/10.1200\/JCO.2011.39.8495","journal-title":"JCO"},{"key":"303_CR73","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.3390\/v4123420","volume":"4","author":"H Iizasa","year":"2012","unstructured":"Iizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H (2012) Epstein-Barr virus (EBV)-associated gastric carcinoma. Viruses 4:3420\u20133439. https:\/\/doi.org\/10.3390\/v4123420","journal-title":"Viruses"},{"key":"303_CR74","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1128\/jvi.72.5.4371-4378.1998","volume":"72","author":"S Imai","year":"1998","unstructured":"Imai S, Nishikawa J, Takada K (1998) Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72:4371\u20134378. https:\/\/doi.org\/10.1128\/jvi.72.5.4371-4378.1998","journal-title":"J Virol"},{"key":"303_CR75","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10120-006-0407-2","volume":"10","author":"S Ishikawa","year":"2007","unstructured":"Ishikawa S, Togashi A, Inoue M, Honda S, Nozawa F, Toyama E, Miyanari N, Tabira Y, Baba H (2007) Indications for EMR\/ESD in cases of early gastric cancer: relationship between histological type, depth of wall invasion, and lymph node metastasis. Gastric Cancer 10:35\u201338. https:\/\/doi.org\/10.1007\/s10120-006-0407-2","journal-title":"Gastric Cancer"},{"key":"303_CR76","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1128\/JVI.72.10.8321-8326.1998","volume":"72","author":"Y Iwasaki","year":"1998","unstructured":"Iwasaki Y, Chong J-M, Hayashi Y, Ikeno R, Arai K, Kitamura M, Koike M, Hirai K, Fukayama M (1998) Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice. J Virol 72:8321\u20138326","journal-title":"J Virol"},{"key":"303_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2021.198399","volume":"297","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xiao H, Sun L, Zhang Y, Liu S, Luo B (2021) LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer. Virus Res 297:198399. https:\/\/doi.org\/10.1016\/j.virusres.2021.198399","journal-title":"Virus Res"},{"key":"303_CR78","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.21873\/anticanres.13555","volume":"39","author":"BW Kang","year":"2019","unstructured":"Kang BW, Baek DW, Kang H, Baek JH, Kim JG (2019) Novel therapeutic approaches for Epstein-Barr virus associated gastric cancer. Anticancer Res 39:4003\u20134010. https:\/\/doi.org\/10.21873\/anticanres.13555","journal-title":"Anticancer Res"},{"key":"303_CR79","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/cancers15020469","volume":"15","author":"B Kim","year":"2023","unstructured":"Kim B, Kim K-M (2023) Role of exosomes and their potential as biomarkers in Epstein-Barr virus-associated gastric cancer. Cancers (Basel) 15:469. https:\/\/doi.org\/10.3390\/cancers15020469","journal-title":"Cancers (Basel)"},{"key":"303_CR80","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1099\/vir.0.045237-0","volume":"94","author":"DN Kim","year":"2013","unstructured":"Kim DN, Seo MK, Choi H, Kim SY, Shin HJ, Yoon A-R, Tao Q, Rha SY, Lee SK (2013) Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1. J Gen Virol 94:497\u2013506. https:\/\/doi.org\/10.1099\/vir.0.045237-0","journal-title":"J Gen Virol"},{"key":"303_CR81","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim K-M, Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M, Lee S, Park SH, Park JO, Park YS, Lim HY, Lee H, Choi M, Talasaz A, Kang PS, Cheng J, Loboda A, Lee J, Kang WK (2018) Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med 24:1449\u20131458. https:\/\/doi.org\/10.1038\/s41591-018-0101-z","journal-title":"Nat Med"},{"key":"303_CR82","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2014.02.002","volume":"26","author":"O Klinke","year":"2014","unstructured":"Klinke O, Feederle R, Delecluse H-J (2014) Genetics of Epstein\u2013Barr virus microRNAs. Semin Cancer Biol 26:52\u201359. https:\/\/doi.org\/10.1016\/j.semcancer.2014.02.002","journal-title":"Semin Cancer Biol"},{"key":"303_CR83","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1002\/jcp.27106","volume":"234","author":"M Kosari-Monfared","year":"2019","unstructured":"Kosari-Monfared M, Nikbakhsh N, Fattahi S, Ghadami E, Ranaei M, Taheri H, Amjadi-Moheb F, Godazandeh GA, Shafaei S, Pilehchian-Langroudi M, Samadani AA, Akhavan-Niaki H (2019) CTNNBIP1 downregulation is associated with tumor grade and viral infections in gastric adenocarcinoma. J Cell Physiol 234:2895\u20132904. https:\/\/doi.org\/10.1002\/jcp.27106","journal-title":"J Cell Physiol"},{"key":"303_CR84","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1158\/1078-0432.CCR-20-0075","volume":"26","author":"Y Kubota","year":"2020","unstructured":"Kubota Y, Kawazoe A, Sasaki A, Mishima S, Sawada K, Nakamura Y, Kotani D, Kuboki Y, Taniguchi H, Kojima T, Doi T, Yoshino T, Ishii G, Kuwata T, Shitara K (2020) The impact of molecular subtype on efficacy of chemotherapy and checkpoint inhibition in advanced gastric cancer. Clin Cancer Res 26:3784\u20133790. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-0075","journal-title":"Clin Cancer Res"},{"key":"303_CR85","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/cncr.21789","volume":"106","author":"M Kusano","year":"2006","unstructured":"Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T (2006) Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG Island methylator phenotype and an association with Epstein\u2013Barr virus. Cancer 106:1467\u20131479. https:\/\/doi.org\/10.1002\/cncr.21789","journal-title":"Cancer"},{"key":"303_CR86","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20040121","volume":"199","author":"SP Lee","year":"2004","unstructured":"Lee SP, Brooks JM, Al-Jarrah H, Thomas WA, Haigh TA, Taylor GS, Humme S, Schepers A, Hammerschmidt W, Yates JL, Rickinson AB, Blake NW (2004) CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1. J Exp Med 199:1409\u20131420. https:\/\/doi.org\/10.1084\/jem.20040121","journal-title":"J Exp Med"},{"key":"303_CR87","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1440-1746.2009.05775.x","volume":"24","author":"J-H Lee","year":"2009","unstructured":"Lee J-H, Kim S-H, Han S-H, An J-S, Lee E-S, Kim Y-S (2009) Clinicopathological and molecular characteristics of Epstein\u2013Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol 24:354\u2013365. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05775.x","journal-title":"J Gastroenterol Hepatol"},{"key":"303_CR88","doi-asserted-by":"crossref","first-page":"31018","DOI":"10.18632\/oncotarget.5041","volume":"6","author":"HG Lee","year":"2015","unstructured":"Lee HG, Kim H, Kim EJ, Park P-G, Dong SM, Choi TH, Kim H, Chong CR, Liu JO, Chen J, Ambinder RF, Hayward SD, Park JH, Lee JM (2015) Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation. Oncotarget 6:31018\u201331029","journal-title":"Oncotarget"},{"key":"303_CR89","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/molecules21101286","volume":"21","author":"HH Lee","year":"2016","unstructured":"Lee HH, Lee S, Shin YS, Cho M, Kang H, Cho H (2016) Anti-cancer effect of quercetin in xenograft models with EBV-associated human gastric carcinoma. Molecules 21:1286. https:\/\/doi.org\/10.3390\/molecules21101286","journal-title":"Molecules"},{"key":"303_CR90","doi-asserted-by":"publisher","unstructured":"Leong MML, Lung ML (2021) The impact of Epstein-Barr virus infection on epigenetic regulation of host cell gene expression in epithelial and lymphocytic malignancies. Front Oncol 11. https:\/\/doi.org\/10.3389\/fonc.2021.629780","DOI":"10.3389\/fonc.2021.629780"},{"key":"303_CR91","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1111\/cas.14978","volume":"112","author":"W Li","year":"2021","unstructured":"Li W, Okabe A, Usui G, Fukuyo M, Matsusaka K, Rahmutulla B, Mano Y, Hoshii T, Funata S, Hiura N, Fukayama M, Tan P, Ushiku T, Kaneda A (2021) Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer. Cancer Sci 112:3349\u20133362. https:\/\/doi.org\/10.1111\/cas.14978","journal-title":"Cancer Sci"},{"key":"303_CR92","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1053\/j.gastro.2014.08.036","volume":"147","author":"Q Liang","year":"2014","unstructured":"Liang Q, Yao X, Tang S, Zhang J, Yau TO, Li X, Tang C-M, Kang W, Lung RWM, Li JW, Chan TF, Xing R, Lu Y, Lo KW, Wong N, To KF, Yu C, Chan FKL, Sung JJY, Yu J (2014) Integrative identification of Epstein\u2013Barr virus\u2013associated mutations and epigenetic alterations in gastric cancer. Gastroenterology 147:1350\u20131362.e4. https:\/\/doi.org\/10.1053\/j.gastro.2014.08.036","journal-title":"Gastroenterology"},{"key":"303_CR93","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrmicro3135","volume":"11","author":"PM Lieberman","year":"2013","unstructured":"Lieberman PM (2013) Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat Rev Microbiol 11:863\u2013875. https:\/\/doi.org\/10.1038\/nrmicro3135","journal-title":"Nat Rev Microbiol"},{"key":"303_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12672-022-00479-0","volume":"13","author":"\u00c1 Lima","year":"2022","unstructured":"Lima \u00c1, Sousa H, Medeiros R, Nobre A, Machado M (2022) PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis. Discov Oncol 13:19. https:\/\/doi.org\/10.1007\/s12672-022-00479-0","journal-title":"Discov Oncol"},{"key":"303_CR95","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15698\/mic2017.09.590","volume":"4","author":"MJ Lista","year":"2017","unstructured":"Lista MJ, Martins RP, Angrand G, Quill\u00e9v\u00e9r\u00e9 A, Daskalogianni C, Voisset C, Teulade-Fichou M-P, F\u00e5hraeus R, Blondel M (2017a) A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness. Microbial Cell 4:305\u2013307. https:\/\/doi.org\/10.15698\/mic2017.09.590","journal-title":"Microbial Cell"},{"key":"303_CR96","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/ncomms16043","volume":"8","author":"MJ Lista","year":"2017","unstructured":"Lista MJ, Martins RP, Billant O, Contesse M-A, Findakly S, Pochard P, Daskalogianni C, Beauvineau C, Guetta C, Jamin C, Teulade-Fichou M-P, F\u00e5hraeus R, Voisset C, Blondel M (2017b) Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA. Nat Commun 8:16043. https:\/\/doi.org\/10.1038\/ncomms16043","journal-title":"Nat Commun"},{"key":"303_CR97","doi-asserted-by":"publisher","first-page":"e02481","DOI":"10.1128\/JVI.02481-20","volume":"95","author":"J Liu","year":"2021","unstructured":"Liu J, Zhang Y, Yu C, Li J, Liu W, Luo B (2021) Epstein-Barr virus-encoded latent membrane protein 2A downregulates GCNT3 via the TGF-\u03b21\/Smad-mTORC1 signaling Axis. J Virol 95:e02481\u2013e02420. https:\/\/doi.org\/10.1128\/JVI.02481-20","journal-title":"J Virol"},{"key":"303_CR98","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11262-022-01925-5","volume":"58","author":"W Liu","year":"2022","unstructured":"Liu W, Xiao H, Song H, An S, Luo B (2022) Transcriptome sequencing of LMP2A-transfected gastric cancer cells identifies potential biomarkers in EBV-associated gastric cancer. Virus Genes 58:515\u2013526. https:\/\/doi.org\/10.1007\/s11262-022-01925-5","journal-title":"Virus Genes"},{"key":"303_CR99","doi-asserted-by":"publisher","first-page":"1204030","DOI":"10.3389\/fonc.2023.1204030","volume":"13","author":"T Liu","year":"2023","unstructured":"Liu T, Zhou X, Zhang Z, Qin Y, Wang R, Qin Y, Huang Y, Mo Y, Huang T (2023) The role of EBV-encoded miRNA in EBV-associated gastric cancer. Front Oncol 13:1204030. https:\/\/doi.org\/10.3389\/fonc.2023.1204030","journal-title":"Front Oncol"},{"key":"303_CR100","doi-asserted-by":"publisher","unstructured":"Low YH, Loh CJL, Peh DYY, Chu AJM, Han S, Toh HC (2023) Pathogenesis and therapeutic implications of EBV-associated epithelial cancers. Front Oncol 13. https:\/\/doi.org\/10.3389\/fonc.2023.1202117","DOI":"10.3389\/fonc.2023.1202117"},{"key":"303_CR101","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12935-023-03154-8","volume":"23","author":"S Lu","year":"2023","unstructured":"Lu S, Duan R, Cong L, Song Y (2023) The effects of ARID1A mutation in gastric cancer and its significance for treatment. Cancer Cell Int 23:296. https:\/\/doi.org\/10.1186\/s12935-023-03154-8","journal-title":"Cancer Cell Int"},{"key":"303_CR102","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3748\/wjg.v11.i5.629","volume":"11","author":"B Luo","year":"2005","unstructured":"Luo B, Wang Y, Wang X-F, Liang H, Yan L-P, Huang B-H, Zhao P (2005) Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. World J Gastroenterol 11:629\u2013633. https:\/\/doi.org\/10.3748\/wjg.v11.i5.629","journal-title":"World J Gastroenterol"},{"key":"303_CR103","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12935-021-01793-3","volume":"21","author":"Y Luo","year":"2021","unstructured":"Luo Y, Liu Y, Wang C, Gan R (2021) Signaling pathways of EBV-induced oncogenesis. Cancer Cell Int 21:93. https:\/\/doi.org\/10.1186\/s12935-021-01793-3","journal-title":"Cancer Cell Int"},{"key":"303_CR104","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ijc.33358","volume":"148","author":"K Lv","year":"2021","unstructured":"Lv K, Li R, Cao Y, Gu Y, Liu X, He X, Jin K, Fang H, Fei Y, Shi M, Liu H, Li H, He H, Lin C, Zhang H, Xu J (2021) Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients. Int J Cancer 148:759\u2013768. https:\/\/doi.org\/10.1002\/ijc.33358","journal-title":"Int J Cancer"},{"key":"303_CR105","doi-asserted-by":"publisher","first-page":"67094","DOI":"10.18632\/oncotarget.17945","volume":"8","author":"J Ma","year":"2017","unstructured":"Ma J, Li J, Hao Y, Nie Y, Li Z, Qian M, Liang Q, Yu J, Zeng M, Wu K (2017) Differentiated tumor immune microenvironment of Epstein\u2013Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy. Oncotarget 8:67094\u201367103. https:\/\/doi.org\/10.18632\/oncotarget.17945","journal-title":"Oncotarget"},{"key":"303_CR106","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, Tirosh I, Bialas AR, Kamitaki N, Martersteck EM, Trombetta JJ, Weitz DA, Sanes JR, Shalek AK, Regev A, McCarroll SA (2015) Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161:1202\u20131214. https:\/\/doi.org\/10.1016\/j.cell.2015.05.002","journal-title":"Cell"},{"key":"303_CR107","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00261-008-9444-0","volume":"34","author":"E Maeda","year":"2009","unstructured":"Maeda E, Akahane M, Uozaki H, Kato N, Hayashi N, Fukayama M, Ohtomo K (2009) CT appearance of Epstein-Barr virus-associated gastric carcinoma. Abdom Imaging 34:618\u2013625. https:\/\/doi.org\/10.1007\/s00261-008-9444-0","journal-title":"Abdom Imaging"},{"key":"303_CR108","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","volume":"110","author":"C Mancao","year":"2007","unstructured":"Mancao C, Hammerschmidt W (2007) Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110:3715\u20133721. https:\/\/doi.org\/10.1182\/blood-2007-05-090142","journal-title":"Blood"},{"key":"303_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107241","volume":"300","author":"RA Mariuzza","year":"2024","unstructured":"Mariuzza RA, Shahid S, Karade SS (2024) The immune checkpoint receptor LAG3: structure, function, and target for cancer immunotherapy. J Biol Chem 300:107241. https:\/\/doi.org\/10.1016\/j.jbc.2024.107241","journal-title":"J Biol Chem"},{"key":"303_CR110","doi-asserted-by":"publisher","first-page":"42","DOI":"10.12998\/wjcc.v3.i1.42","volume":"3","author":"T Matsuoka","year":"2015","unstructured":"Matsuoka T, Yashiro M (2015) Recent advances in the HER2 targeted therapy of gastric cancer. World J Clin Cases 3:42\u201351. https:\/\/doi.org\/10.12998\/wjcc.v3.i1.42","journal-title":"World J Clin Cases"},{"key":"303_CR111","doi-asserted-by":"publisher","unstructured":"Miliotis CN, Slack FJ (2020) Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancer. J Cancer Metastasis Treat 6. https:\/\/doi.org\/10.20517\/2394-4722.2020.12","DOI":"10.20517\/2394-4722.2020.12"},{"key":"303_CR112","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/cas.13424","volume":"109","author":"K Mimura","year":"2018","unstructured":"Mimura K, Teh JL, Okayama H, Shiraishi K, Kua L-F, Koh V, Smoot DT, Ashktorab H, Oike T, Suzuki Y, Fazreen Z, Asuncion BR, Shabbir A, Yong W-P, So J, Soong R, Kono K (2018) PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer Sci 109:43\u201353. https:\/\/doi.org\/10.1111\/cas.13424","journal-title":"Cancer Sci"},{"key":"303_CR113","doi-asserted-by":"publisher","first-page":"694","DOI":"10.7150\/ijbs.36595","volume":"16","author":"K Min","year":"2020","unstructured":"Min K, Kim JY, Lee SK (2020) Epstein-Barr virus miR-BART1-3p suppresses apoptosis and promotes migration of gastric carcinoma cells by targeting DAB2. Int J Biol Sci 16:694\u2013707. https:\/\/doi.org\/10.7150\/ijbs.36595","journal-title":"Int J Biol Sci"},{"key":"303_CR114","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40425-019-0514-3","volume":"7","author":"S Mishima","year":"2019","unstructured":"Mishima S, Kawazoe A, Nakamura Y, Sasaki A, Kotani D, Kuboki Y, Bando H, Kojima T, Doi T, Ohtsu A, Yoshino T, Kuwata T, Tsuji A, Shitara K (2019) Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer. J Immunother Cancer 7:24. https:\/\/doi.org\/10.1186\/s40425-019-0514-3","journal-title":"J Immunother Cancer"},{"key":"303_CR115","doi-asserted-by":"publisher","first-page":"17810","DOI":"10.1038\/s41598-017-18132-0","volume":"7","author":"JW Moon","year":"2017","unstructured":"Moon JW, Kong S-K, Kim BS, Kim HJ, Lim H, Noh K, Kim Y, Choi J-W, Lee J-H, Kim Y-S (2017) IFN\u03b3 induces PD-L1 overexpression by JAK2\/STAT1\/IRF-1 signaling in EBV-positive gastric carcinoma. Sci Rep 7:17810. https:\/\/doi.org\/10.1038\/s41598-017-18132-0","journal-title":"Sci Rep"},{"key":"303_CR116","doi-asserted-by":"publisher","unstructured":"Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, Meheus F, Verhoeven RHA, Vignat J, Laversanne M, Ferlay J, Soerjomataram I (2022) The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: a population-based modelling study. eClinicalMedicine 47. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101404","DOI":"10.1016\/j.eclinm.2022.101404"},{"key":"303_CR117","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.3748\/wjg.v20.i16.4536","volume":"20","author":"A Morishita","year":"2014","unstructured":"Morishita A, Gong J, Masaki T (2014) Targeting receptor tyrosine kinases in gastric cancer. World J Gastroenterol 20:4536\u20134545. https:\/\/doi.org\/10.3748\/wjg.v20.i16.4536","journal-title":"World J Gastroenterol"},{"key":"303_CR118","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00428-001-0566-9","volume":"440","author":"S Moritani","year":"2002","unstructured":"Moritani S, Sugihara H, Kushima R, Hattori T (2002) Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology. Virchows Arch 440:367\u2013375. https:\/\/doi.org\/10.1007\/s00428-001-0566-9","journal-title":"Virchows Arch"},{"key":"303_CR119","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1053\/j.gastro.2009.05.001","volume":"137","author":"G Murphy","year":"2009","unstructured":"Murphy G, Pfeiffer R, Camargo MC, Rabkin CS (2009) Meta-analysis shows that prevalence of Epstein\u2013Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 137:824\u2013833. https:\/\/doi.org\/10.1053\/j.gastro.2009.05.001","journal-title":"Gastroenterology"},{"key":"303_CR120","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jmv.24634","volume":"89","author":"M Nakamura","year":"2017","unstructured":"Nakamura M, Nishikawa J, Saito M, Sakai K, Sasaki S, Hashimoto S, Okamoto T, Suehiro Y, Yamasaki T, Sakaida I (2017) Decitabine inhibits tumor cell proliferation and up-regulates e-cadherin expression in Epstein\u2013Barr virus-associated gastric cancer. J Med Virol 89:508\u2013517. https:\/\/doi.org\/10.1002\/jmv.24634","journal-title":"J Med Virol"},{"key":"303_CR121","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s41598-021-81667-w","volume":"11","author":"H Nakano","year":"2021","unstructured":"Nakano H, Saito M, Nakajima S, Saito K, Nakayama Y, Kase K, Yamada L, Kanke Y, Hanayama H, Onozawa H, Okayama H, Fujita S, Sakamoto W, Saze Z, Momma T, Mimura K, Ohki S, Goto A, Kono K (2021) PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms. Sci Rep 11:1982. https:\/\/doi.org\/10.1038\/s41598-021-81667-w","journal-title":"Sci Rep"},{"key":"303_CR122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211358","volume":"14","author":"A Nakayama","year":"2019","unstructured":"Nakayama A, Abe H, Kunita A, Saito R, Kanda T, Yamashita H, Seto Y, Ishikawa S, Fukayama M (2019) Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein\u2013Barr virus-associated gastric carcinoma. PLoS One 14:e0211358. https:\/\/doi.org\/10.1371\/journal.pone.0211358","journal-title":"PLoS One"},{"key":"303_CR123","doi-asserted-by":"publisher","first-page":"81512","DOI":"10.18632\/oncotarget.13130","volume":"7","author":"H Namba-Fukuyo","year":"2016","unstructured":"Namba-Fukuyo H, Funata S, Matsusaka K, Fukuyo M, Rahmutulla B, Mano Y, Fukayama M, Aburatani H, Kaneda A (2016) TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection. Oncotarget 7:81512\u201381526. https:\/\/doi.org\/10.18632\/oncotarget.13130","journal-title":"Oncotarget"},{"key":"303_CR124","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1099\/jgv.0.000605","volume":"97","author":"A Nanbo","year":"2016","unstructured":"Nanbo A, Kachi K, Yoshiyama H, Ohba Y (2016) Epstein\u2013Barr virus exploits host endocytic machinery for cell-to-cell viral transmission rather than a virological synapse. J Gen Virol 97:2989\u20133006. https:\/\/doi.org\/10.1099\/jgv.0.000605","journal-title":"J Gen Virol"},{"key":"303_CR125","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ctrv.2018.03.006","volume":"66","author":"M Naseem","year":"2018","unstructured":"Naseem M, Barzi A, Brezden-Masley C, Puccini A, Berger MD, Tokunaga R, Battaglin F, Soni S, McSkane M, Zhang W, Lenz H-J (2018) Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 66:15\u201322. https:\/\/doi.org\/10.1016\/j.ctrv.2018.03.006","journal-title":"Cancer Treat Rev"},{"key":"303_CR126","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/cancers10060167","volume":"10","author":"J Nishikawa","year":"2018","unstructured":"Nishikawa J, Iizasa H, Yoshiyama H, Shimokuri K, Kobayashi Y, Sasaki S, Nakamura M, Yanai H, Sakai K, Suehiro Y, Yamasaki T, Sakaida I (2018) Clinical importance of Epstein\u2013Barr virus-associated gastric cancer. Cancers 10:167. https:\/\/doi.org\/10.3390\/cancers10060167","journal-title":"Cancers"},{"key":"303_CR127","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.virol.2003.12.005","volume":"320","author":"ST Oh","year":"2004","unstructured":"Oh ST, Seo JS, Moon UY, Kang KH, Shin D-J, Yoon SK, Kim WH, Park J-G, Lee SK (2004) A naturally derived gastric cancer cell line shows latency I Epstein\u2013Barr virus infection closely resembling EBV-associated gastric cancer. Virology 320:330\u2013336. https:\/\/doi.org\/10.1016\/j.virol.2003.12.005","journal-title":"Virology"},{"key":"303_CR128","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.1038\/s41598-017-08370-7","volume":"7","author":"A Okabe","year":"2017","unstructured":"Okabe A, Funata S, Matsusaka K, Namba H, Fukuyo M, Rahmutulla B, Oshima M, Iwama A, Fukayama M, Kaneda A (2017) Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus. Sci Rep 7:7924. https:\/\/doi.org\/10.1038\/s41598-017-08370-7","journal-title":"Sci Rep"},{"key":"303_CR129","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41588-020-0665-7","volume":"52","author":"A Okabe","year":"2020","unstructured":"Okabe A, Huang KK, Matsusaka K, Fukuyo M, Xing M, Ong X, Hoshii T, Usui G, Seki M, Mano Y, Rahmutulla B, Kanda T, Suzuki T, Rha SY, Ushiku T, Fukayama M, Tan P, Kaneda A (2020) Cross-species chromatin interactions drive transcriptional rewiring in Epstein\u2013Barr virus\u2013positive gastric adenocarcinoma. Nat Genet 52:919\u2013930. https:\/\/doi.org\/10.1038\/s41588-020-0665-7","journal-title":"Nat Genet"},{"key":"303_CR130","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10120-024-01523-4","volume":"27","author":"A Ooki","year":"2024","unstructured":"Ooki A, Osumi H, Yoshino K, Yamaguchi K (2024) Potent therapeutic strategy in gastric cancer with microsatellite instability-high and\/or deficient mismatch repair. Gastric Cancer 27:907\u2013931. https:\/\/doi.org\/10.1007\/s10120-024-01523-4","journal-title":"Gastric Cancer"},{"key":"303_CR131","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/den.13584","volume":"32","author":"H Osumi","year":"2020","unstructured":"Osumi H, Kawachi H, Yoshio T, Fujisaki J (2020) Clinical impact of Epstein-Barr virus status on the incidence of lymph node metastasis in early gastric cancer. Dig Endosc 32:316\u2013322. https:\/\/doi.org\/10.1111\/den.13584","journal-title":"Dig Endosc"},{"key":"303_CR132","doi-asserted-by":"publisher","first-page":"10936","DOI":"10.3390\/ijms222010936","volume":"22","author":"MC Park","year":"2021","unstructured":"Park MC, Kim H, Choi H, Chang MS, Lee SK (2021) Epstein-Barr virus miR-BART1-3p regulates the miR-17-92 cluster by targeting E2F3. Int J Mol Sci 22:10936. https:\/\/doi.org\/10.3390\/ijms222010936","journal-title":"Int J Mol Sci"},{"key":"303_CR133","doi-asserted-by":"publisher","unstructured":"Polakovicova I, Jerez S, Wichmann IA, Sandoval-B\u00f3rquez A, Carrasco-V\u00e9liz N, Corval\u00e1n AH (2018) Role of microRNAs and exosomes in helicobacter pylori and Epstein-Barr virus associated gastric cancers. Front Microbiol 9. https:\/\/doi.org\/10.3389\/fmicb.2018.00636","DOI":"10.3389\/fmicb.2018.00636"},{"key":"303_CR134","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrg.2017.15","volume":"18","author":"SM Prakadan","year":"2017","unstructured":"Prakadan SM, Shalek AK, Weitz DA (2017) Scaling by shrinking: empowering single-cell \u201comics\u201d with microfluidic devices. Nat Rev Genet 18:345\u2013361. https:\/\/doi.org\/10.1038\/nrg.2017.15","journal-title":"Nat Rev Genet"},{"key":"303_CR135","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.virol.2009.01.006","volume":"386","author":"ZL Pratt","year":"2009","unstructured":"Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B (2009) The microRNAs of Epstein-Barr virus are expressed at dramatically differing levels among cell lines. Virology 386:387\u2013397. https:\/\/doi.org\/10.1016\/j.virol.2009.01.006","journal-title":"Virology"},{"key":"303_CR136","doi-asserted-by":"publisher","first-page":"175883592093743","DOI":"10.1177\/1758835920937434","volume":"12","author":"M-Z Qiu","year":"2020","unstructured":"Qiu M-Z, He C-Y, Yang D-J, Zhou D-L, Zhao B-W, Wang X-J, Yang L-Q, Lu S-X, Wang F-H, Xu R-H (2020) Observational cohort study of clinical outcome in Epstein\u2013Barr virus associated gastric cancer patients. Ther Adv Med Oncol 12:1758835920937434. https:\/\/doi.org\/10.1177\/1758835920937434","journal-title":"Ther Adv Med Oncol"},{"key":"303_CR137","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41392-023-01622-1","volume":"8","author":"M-Z Qiu","year":"2023","unstructured":"Qiu M-Z, Wang C, Wu Z, Zhao Q, Zhao Z, Huang C-Y, Wu W, Yang L-Q, Zhou Z-W, Zheng Y, Pan H-M, Liu Z, Zeng Z-L, Luo H-Y, Wang F, Wang F-H, Yang S-Y, Huang M-X, Lian Z, Zhang H, Xu R-H (2023) Dynamic single-cell mapping unveils Epstein\u2013Barr virus-imprinted T-cell exhaustion and on-treatment response. Signal Transduct Target Ther 8:370. https:\/\/doi.org\/10.1038\/s41392-023-01622-1","journal-title":"Signal Transduct Target Ther"},{"key":"303_CR138","doi-asserted-by":"publisher","first-page":"9400","DOI":"10.3390\/ijms21249400","volume":"21","author":"VD Re","year":"2020","unstructured":"Re VD, Brisotto G, Repetto O, De Zorzi M, Caggiari L, Zanussi S, Alessandrini L, Canzonieri V, Miolo G, Puglisi F, Belluco C, Steffan A, Cannizzaro R (2020) Overview of Epstein\u2013Barr-virus-associated gastric cancer correlated with prognostic classification and development of therapeutic options. Int J Mol Sci 21:9400. https:\/\/doi.org\/10.3390\/ijms21249400","journal-title":"Int J Mol Sci"},{"key":"303_CR139","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/jmv.23405","volume":"85","author":"M Saito","year":"2013","unstructured":"Saito M, Nishikawa J, Okada T, Morishige A, Sakai K, Nakamura M, Kiyotoki S, Hamabe K, Okamoto T, Oga A, Sasaki K, Suehiro Y, Hinoda Y, Sakaida I (2013) Role of DNA methylation in the development of Epstein\u2013Barr virus-associated gastric carcinoma. J Med Virol 85:121\u2013127. https:\/\/doi.org\/10.1002\/jmv.23405","journal-title":"J Med Virol"},{"key":"303_CR140","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/modpathol.2016.202","volume":"30","author":"R Saito","year":"2017","unstructured":"Saito R, Abe H, Kunita A, Yamashita H, Seto Y, Fukayama M (2017) Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein\u2013Barr virus-associated gastric cancer: the prognostic implications. Mod Pathol 30:427\u2013439. https:\/\/doi.org\/10.1038\/modpathol.2016.202","journal-title":"Mod Pathol"},{"key":"303_CR141","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1158\/2159-8290.CD-20-1312","volume":"11","author":"D Salas-Benito","year":"2021","unstructured":"Salas-Benito D, P\u00e9rez-Gracia JL, Ponz-Sarvis\u00e9 M, Rodriguez-Ruiz ME, Mart\u00ednez-Forero I, Casta\u00f1\u00f3n E, L\u00f3pez-Picazo JM, Sanmamed MF, Melero I (2021) Paradigms on immunotherapy combinations with chemotherapy. Cancer Discov 11:1353\u20131367. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1312","journal-title":"Cancer Discov"},{"key":"303_CR142","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.3390\/cancers15123178","volume":"15","author":"MY Salnikov","year":"2023","unstructured":"Salnikov MY, Fonseca GJ, Mymryk JS (2023a) Differences in the tumor microenvironment of EBV-associated gastric cancers revealed using single-cell transcriptome analysis. Cancers 15:3178. https:\/\/doi.org\/10.3390\/cancers15123178","journal-title":"Cancers"},{"key":"303_CR143","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/v15040853","volume":"15","author":"MY Salnikov","year":"2023","unstructured":"Salnikov MY, Wang E, Christensen E, Prusinkiewicz MA, Shooshtari P, Mymryk JS (2023b) The EBV gastric cancer resource (EBV-GCR): a suite of tools for investigating EBV-associated human gastric carcinogenesis. Viruses 15:853. https:\/\/doi.org\/10.3390\/v15040853","journal-title":"Viruses"},{"key":"303_CR144","doi-asserted-by":"publisher","first-page":"1358511","DOI":"10.3389\/fimmu.2024.1358511","volume":"15","author":"MY Salnikov","year":"2024","unstructured":"Salnikov MY, MacNeil KM, Mymryk JS (2024) The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape. Front Immunol 15:1358511. https:\/\/doi.org\/10.3389\/fimmu.2024.1358511","journal-title":"Front Immunol"},{"key":"303_CR145","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1128\/jvi.66.8.4654-4661.1992","volume":"66","author":"J Sample","year":"1992","unstructured":"Sample J, Henson EB, Sample C (1992) The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol 66:4654\u20134661. https:\/\/doi.org\/10.1128\/jvi.66.8.4654-4661.1992","journal-title":"J Virol"},{"key":"303_CR146","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41591-018-0012-z","volume":"24","author":"J Shen","year":"2018","unstructured":"Shen J, Ju Z, Zhao W, Wang L, Peng Y, Ge Z, Nagel ZD, Zou J, Wang C, Kapoor P, Ma X, Ma D, Liang J, Song S, Liu J, Samson LD, Ajani JA, Li G-M, Liang H, Shen X, Mills GB, Peng G (2018) ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade. Nat Med 24:556\u2013562. https:\/\/doi.org\/10.1038\/s41591-018-0012-z","journal-title":"Nat Med"},{"key":"303_CR147","first-page":"116","volume":"2","author":"J Shi","year":"2012","unstructured":"Shi J, Zhang G, Yao D, Liu W, Wang N, Ji M, He N, Shi B, Hou P (2012) Prognostic significance of aberrant gene methylation in gastric cancer. Am J Cancer Res 2:116\u2013129","journal-title":"Am J Cancer Res"},{"key":"303_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2021.198567","volume":"305","author":"D Shi","year":"2021","unstructured":"Shi D, Zhang Y, Mao T, Liu D, Liu W, Luo B (2021) MiR-BART2-3p targets Unc-51-like kinase 1 and inhibits cell autophagy and migration in Epstein-Barr virus-associated gastric cancer. Virus Res 305:198567. https:\/\/doi.org\/10.1016\/j.virusres.2021.198567","journal-title":"Virus Res"},{"key":"303_CR149","first-page":"769","volume":"140","author":"D Shibata","year":"1992","unstructured":"Shibata D, Weiss LM (1992) Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140:769\u2013774","journal-title":"Am J Pathol"},{"key":"303_CR150","first-page":"469","volume":"139","author":"D Shibata","year":"1991","unstructured":"Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM (1991) Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139:469\u2013474","journal-title":"Am J Pathol"},{"key":"303_CR151","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1128\/jvi.70.10.7260-7263.1996","volume":"70","author":"N Shimizu","year":"1996","unstructured":"Shimizu N, Yoshiyama H, Takada K (1996) Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol 70:7260\u20137263. https:\/\/doi.org\/10.1128\/jvi.70.10.7260-7263.1996","journal-title":"J Virol"},{"key":"303_CR152","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3892\/ijo.2015.2856","volume":"46","author":"A Shinozaki-Ushiku","year":"2015","unstructured":"Shinozaki-Ushiku A, Kunita A, Fukayama M (2015a) Update on Epstein-Barr virus and gastric cancer (review). Int J Oncol 46:1421\u20131434. https:\/\/doi.org\/10.3892\/ijo.2015.2856","journal-title":"Int J Oncol"},{"key":"303_CR153","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1128\/jvi.03639-14","volume":"89","author":"A Shinozaki-Ushiku","year":"2015","unstructured":"Shinozaki-Ushiku A, Kunita A, Isogai M, Hibiya T, Ushiku T, Takada K, Fukayama M (2015b) Profiling of virus-encoded MicroRNAs in Epstein-Barr virus-associated gastric carcinoma and their roles in gastric carcinogenesis. J Virol 89:5581\u20135591. https:\/\/doi.org\/10.1128\/jvi.03639-14","journal-title":"J Virol"},{"key":"303_CR154","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1128\/jvi.05623-11","volume":"86","author":"N Sivachandran","year":"2012","unstructured":"Sivachandran N, Dawson CW, Young LS, Liu F-F, Middeldorp J, Frappier L (2012) Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol 86:60\u201368. https:\/\/doi.org\/10.1128\/jvi.05623-11","journal-title":"J Virol"},{"key":"303_CR155","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5009\/gnl.2011.5.2.143","volume":"5","author":"H-J Song","year":"2011","unstructured":"Song H-J, Kim K-M (2011) Pathology of Epstein-Barr virus-associated gastric carcinoma and its relationship to prognosis. Gut Liver 5:143\u2013148. https:\/\/doi.org\/10.5009\/gnl.2011.5.2.143","journal-title":"Gut Liver"},{"key":"303_CR156","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.gastro.2010.04.002","volume":"139","author":"H-J Song","year":"2010","unstructured":"Song H-J, Srivastava A, Lee J, Kim YS, Kim K-M, Kang WK, Kim M, Kim S, Park CK, Kim S (2010) Host inflammatory response predicts survival of patients with Epstein-Barr virus\u2013associated gastric carcinoma. Gastroenterology 139:84\u201392. https:\/\/doi.org\/10.1053\/j.gastro.2010.04.002","journal-title":"Gastroenterology"},{"key":"303_CR157","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.dld.2021.06.004","volume":"54","author":"H Song","year":"2022","unstructured":"Song H, Zhang Y, Liu J, Liu W, Luo B (2022) Activation of DNA methyltransferase 3a by Epstein-Barr nuclear antigen 1 in gastric carcinoma. Dig Liver Dis 54:973\u2013983. https:\/\/doi.org\/10.1016\/j.dld.2021.06.004","journal-title":"Dig Liver Dis"},{"key":"303_CR158","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3748\/wjg.14.4347","volume":"14","author":"H Sousa","year":"2008","unstructured":"Sousa H, Pinto-Correia AL, Medeiros R, Dinis-Ribeiro M (2008) Epstein-Barr virus is associated with gastric carcinoma: the question is what is the significance? World J Gastroenterol 14:4347. https:\/\/doi.org\/10.3748\/wjg.14.4347","journal-title":"World J Gastroenterol"},{"key":"303_CR159","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/v12111222","volume":"12","author":"LJ Stanland","year":"2020","unstructured":"Stanland LJ, Luftig MA (2020) The role of EBV-induced Hypermethylation in gastric cancer tumorigenesis. Viruses 12:1222. https:\/\/doi.org\/10.3390\/v12111222","journal-title":"Viruses"},{"key":"303_CR160","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/bjc.1996.412","volume":"74","author":"M Sugiura","year":"1996","unstructured":"Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T (1996) Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer 74:625\u2013631. https:\/\/doi.org\/10.1038\/bjc.1996.412","journal-title":"Br J Cancer"},{"key":"303_CR161","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.3390\/ijms19092810","volume":"19","author":"L Sun","year":"2018","unstructured":"Sun L, Meckes DG (2018) Methodological approaches to study extracellular vesicle miRNAs in Epstein\u2013Barr virus-associated cancers. Int J Mol Sci 19:2810. https:\/\/doi.org\/10.3390\/ijms19092810","journal-title":"Int J Mol Sci"},{"key":"303_CR162","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/mp.53.5.255","volume":"53","author":"K Takada","year":"2000","unstructured":"Takada K (2000) Epstein-Barr virus and gastric carcinoma. Mol Pathol 53:255\u2013261","journal-title":"Mol Pathol"},{"key":"303_CR163","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"HA Tawbi","year":"2022","unstructured":"Tawbi HA, Schadendorf D, Lipson EJ, Ascierto PA, Matamala L, Guti\u00e9rrez EC, Rutkowski P, Gogas HJ, Lao CD, Menezes JJD, Dalle S, Arance A, Grob J-J, Srivastava S, Abaskharoun M, Hamilton M, Keidel S, Simonsen KL, Sobiesk AM, Li B, Hodi FS, Long GV (2022) Relatlimab and Nivolumab versus Nivolumab in untreated advanced melanoma. N Engl J Med 386:24\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2109970","journal-title":"N Engl J Med"},{"key":"303_CR164","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.7150\/ijbs.19531","volume":"13","author":"S-Y Teow","year":"2017","unstructured":"Teow S-Y, Liew K, Khoo AS-B, Peh S-C (2017) Pathogenic role of exosomes in Epstein-Barr virus (EBV)-associated cancers. Int J Biol Sci 13:1276\u20131286. https:\/\/doi.org\/10.7150\/ijbs.19531","journal-title":"Int J Biol Sci"},{"key":"303_CR165","first-page":"1250","volume":"143","author":"M Tokunaga","year":"1993","unstructured":"Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E (1993) Epstein-Barr virus in gastric carcinoma. Am J Pathol 143:1250\u20131254","journal-title":"Am J Pathol"},{"key":"303_CR166","first-page":"607","volume":"3","author":"Y Uemura","year":"1994","unstructured":"Uemura Y, Tokunaga M, Arikawa J, Yamamoto N, Hamasaki Y, Tanaka S, Sato E, Land CE (1994) A unique morphology of Epstein-Barr virus-related early gastric carcinoma. Cancer Epidemiol Biomarkers Prev 3:607\u2013611","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"303_CR167","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1200\/JCO.2004.08.061","volume":"22","author":"J van Beek","year":"2004","unstructured":"van Beek J et al (2004) EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. JCO 22:664\u2013670. https:\/\/doi.org\/10.1200\/JCO.2004.08.061","journal-title":"JCO"},{"key":"303_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2023.109901","volume":"588","author":"N Varshney","year":"2023","unstructured":"Varshney N, Murmu S, Baral B, Kashyap D, Singh S, Kandpal M, Bhandari V, Chaurasia A, Kumar S, Jha HC (2023) Unraveling the Aurora kinase a and Epstein-Barr nuclear antigen 1 axis in Epstein Barr virus associated gastric cancer. Virology 588:109901. https:\/\/doi.org\/10.1016\/j.virol.2023.109901","journal-title":"Virology"},{"issue":"1","key":"303_CR169","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12885-024-13260-z","volume":"25","author":"N Varshney","year":"2024","unstructured":"Varshney N, Singh S, Kandpal M, Saini V, Roberston ES, Jha HC (2024) Interplay of Aurora kinase a functional residues and Epstein-Barr nuclear antigen 1 in Epstein-Barr virus associated gastric cancer. BMC Cancer 25(1):143","journal-title":"BMC Cancer"},{"key":"303_CR170","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20031219","volume":"199","author":"KS Voo","year":"2004","unstructured":"Voo KS, Fu T, Wang HY, Tellam J, Heslop HE, Brenner MK, Rooney CM, Wang R-F (2004) Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med 199:459\u2013470. https:\/\/doi.org\/10.1084\/jem.20031219","journal-title":"J Exp Med"},{"key":"303_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-018-0049-3","volume":"7","author":"F Wang","year":"2018","unstructured":"Wang F, Li B, Wei Y, Zhao Y, Wang L, Zhang P, Yang J, He W, Chen H, Jiao Z, Li Y (2018) Tumor-derived exosomes induce PD1+ macrophage population in human gastric cancer that promotes disease progression. Oncogenesis 7:1\u201311. https:\/\/doi.org\/10.1038\/s41389-018-0049-3","journal-title":"Oncogenesis"},{"key":"303_CR172","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/annonc\/mdz197","volume":"30","author":"F Wang","year":"2019","unstructured":"Wang F, Wei XL, Wang FH, Xu N, Shen L, Dai GH, Yuan XL, Chen Y, Yang SJ, Shi JH, Hu XC, Lin XY, Zhang QY, Feng JF, Ba Y, Liu YP, Li W, Shu YQ, Jiang Y, Li Q, Wang JW, Wu H, Feng H, Yao S, Xu RH (2019a) Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib\/II clinical trial NCT02915432. Ann Oncol 30:1479\u20131486. https:\/\/doi.org\/10.1093\/annonc\/mdz197","journal-title":"Ann Oncol"},{"key":"303_CR173","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.virol.2019.06.006","volume":"534","author":"J Wang","year":"2019","unstructured":"Wang J, Liu W, Zhang X, Zhang Y, Xiao H, Luo B (2019b) LMP2A induces DNA methylation and expression repression of AQP3 in EBV-associated gastric carcinoma. Virology 534:87\u201395. https:\/\/doi.org\/10.1016\/j.virol.2019.06.006","journal-title":"Virology"},{"key":"303_CR174","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1074\/jbc.RA118.006853","volume":"294","author":"J Wang","year":"2019","unstructured":"Wang J, Zheng X, Qin Z, Wei L, Lu Y, Peng Q, Gao Y, Zhang X, Zhang X, Li Z, Fu Y, Liu P, Liu C, Yan Q, Xiong W, Li G, Lu J, Ma J (2019c) Epstein\u2013Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer. J Biol Chem 294:4854\u20134866. https:\/\/doi.org\/10.1074\/jbc.RA118.006853","journal-title":"J Biol Chem"},{"key":"303_CR175","doi-asserted-by":"publisher","first-page":"1938381","DOI":"10.1080\/2162402X.2021.1938381","volume":"10","author":"X-L Wei","year":"2021","unstructured":"Wei X-L, Liu Q-W, Liu F-R, Yuan S-S, Li X-F, Li J-N, Yang A-L, Ling Y-H (2021) The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer. Onco Targets Ther 10:1938381. https:\/\/doi.org\/10.1080\/2162402X.2021.1938381","journal-title":"Onco Targets Ther"},{"key":"303_CR176","doi-asserted-by":"publisher","first-page":"11036","DOI":"10.1073\/pnas.1513359112","volume":"112","author":"D Xiong","year":"2015","unstructured":"Xiong D, Du Y, Wang H-B, Zhao B, Zhang H, Li Y, Hu L-J, Cao J-Y, Zhong Q, Liu W-L, Li M-Z, Zhu X-F, Tsao SW, Hutt-Fletcher LM, Song E, Zeng Y-X, Kieff E, Zeng M-S (2015) Nonmuscle myosin heavy chain IIA mediates Epstein\u2013Barr virus infection of nasopharyngeal epithelial cells. Proc Natl Acad Sci 112:11036\u201311041. https:\/\/doi.org\/10.1073\/pnas.1513359112","journal-title":"Proc Natl Acad Sci"},{"key":"303_CR177","doi-asserted-by":"publisher","first-page":"e00881","DOI":"10.1128\/jvi.00881-23","volume":"97","author":"M Xu","year":"2023","unstructured":"Xu M, Lin J, Yang S, Yao J, Chen M, Feng J, Zhang L, Zhou L, Zhang J, Qin Q (2023) Epstein-Barr virus-encoded miR-BART11-3p modulates the DUSP6-MAPK axis to promote gastric cancer cell proliferation and metastasis. J Virol 97:e00881\u2013e00823. https:\/\/doi.org\/10.1128\/jvi.00881-23","journal-title":"J Virol"},{"key":"303_CR178","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10120-020-01094-0","volume":"24","author":"L Yamada","year":"2021","unstructured":"Yamada L, Saito M, Thar Min AK, Saito K, Ashizawa M, Kase K, Nakajima S, Onozawa H, Okayama H, Endo H, Fujita S, Sakamoto W, Saze Z, Momma T, Mimura K, Ohki S, Kono K (2021) Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer. Gastric Cancer 24:60\u201371. https:\/\/doi.org\/10.1007\/s10120-020-01094-0","journal-title":"Gastric Cancer"},{"key":"303_CR179","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.2169\/internalmedicine.3055-19","volume":"58","author":"H Yanai","year":"2019","unstructured":"Yanai H, Chihara D, Harano M, Sakaguchi E, Murakami T, Nishikawa J (2019) Epstein-Barr virus-associated early gastric cancer treated with endoscopic submucosal dissection: a possible candidate for extended criteria of endoscopic submucosal dissection. Intern Med 58:3247\u20133250. https:\/\/doi.org\/10.2169\/internalmedicine.3055-19","journal-title":"Intern Med"},{"key":"303_CR180","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/stem.634","volume":"29","author":"P Yang","year":"2011","unstructured":"Yang P, Wang Y, Chen J, Li H, Kang L, Zhang Y, Chen S, Zhu B, Gao S (2011) RCOR2 is a subunit of the LSD1 complex that regulates ESC property and substitutes for SOX2 in reprogramming somatic cells to pluripotency. Stem Cells 29:791\u2013801. https:\/\/doi.org\/10.1002\/stem.634","journal-title":"Stem Cells"},{"key":"303_CR181","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2020.09.019","volume":"495","author":"J Yang","year":"2020","unstructured":"Yang J, Liu Z, Zeng B, Hu G, Gan R (2020) Epstein\u2013Barr virus-associated gastric cancer: a distinct subtype. Cancer Lett 495:191\u2013199. https:\/\/doi.org\/10.1016\/j.canlet.2020.09.019","journal-title":"Cancer Lett"},{"key":"303_CR182","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/vim.2022.0200","volume":"36","author":"Y Yao","year":"2023","unstructured":"Yao Y, Kong W, Yang L, Ding Y, Cui H (2023) Immunity and immune evasion mechanisms of Epstein\u2013Barr virus. Viral Immunol 36:303\u2013317. https:\/\/doi.org\/10.1089\/vim.2022.0200","journal-title":"Viral Immunol"},{"key":"303_CR183","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.3390\/cells10113247","volume":"10","author":"L Ye","year":"2021","unstructured":"Ye L, Zhu Z, Chen X, Zhang H, Huang J, Gu S, Zhao X (2021) The importance of Exosomal PD-L1 in cancer progression and its potential as a therapeutic target. Cells 10:3247. https:\/\/doi.org\/10.3390\/cells10113247","journal-title":"Cells"},{"key":"303_CR184","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1101\/gad.1158803","volume":"17","author":"R Yi","year":"2003","unstructured":"Yi R, Qin Y, Macara IG, Cullen BR (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17:3011\u20133016. https:\/\/doi.org\/10.1101\/gad.1158803","journal-title":"Genes Dev"},{"key":"303_CR185","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","volume":"22","author":"LS Young","year":"2003","unstructured":"Young LS, Murray PG (2003) Epstein\u2013Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22:5108\u20135121. https:\/\/doi.org\/10.1038\/sj.onc.1206556","journal-title":"Oncogene"},{"key":"303_CR186","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG (2016) Epstein\u2013Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer 16:789\u2013802. https:\/\/doi.org\/10.1038\/nrc.2016.92","journal-title":"Nat Rev Cancer"},{"key":"303_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2022.198947","volume":"322","author":"C Yu","year":"2022","unstructured":"Yu C, Zhang X, Wang J, Song H, Liu W, Luo B (2022) Molecular mechanism of aquaporin 3 (AQP3) regulating by LMP2A and its crosstalk with 4E-BP1 via ERK signaling pathway in EBV-associated gastric cancer. Virus Res 322:198947. https:\/\/doi.org\/10.1016\/j.virusres.2022.198947","journal-title":"Virus Res"},{"key":"303_CR188","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jcmm.13354","volume":"22","author":"J Zhang","year":"2018","unstructured":"Zhang J, Huang T, Zhou Y, Cheng ASL, Yu J, To KF, Kang W (2018) The oncogenic role of Epstein\u2013Barr virus-encoded microRNAs in Epstein\u2013Barr virus-associated gastric carcinoma. J Cell Mol Med 22:38\u201345. https:\/\/doi.org\/10.1111\/jcmm.13354","journal-title":"J Cell Mol Med"},{"key":"303_CR189","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","volume":"70","author":"M Zhang","year":"2021","unstructured":"Zhang M, Hu S, Min M, Ni Y, Lu Z, Sun X, Wu J, Liu B, Ying X, Liu Y (2021) Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut 70:464\u2013475. https:\/\/doi.org\/10.1136\/gutjnl-2019-320368","journal-title":"Gut"},{"key":"303_CR190","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1007\/s00253-022-12029-3","volume":"106","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang R, Xie Z (2022) The roles of DNA methylation on the promotor of the Epstein\u2013Barr virus (EBV) gene and the genome in patients with EBV-associated diseases. Appl Microbiol Biotechnol 106:4413\u20134426. https:\/\/doi.org\/10.1007\/s00253-022-12029-3","journal-title":"Appl Microbiol Biotechnol"},{"key":"303_CR191","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/cncr.27724","volume":"119","author":"J Zhao","year":"2013","unstructured":"Zhao J, Liang Q, Cheung K-F, Kang W, Lung RWM, Tong JHM, To KF, Sung JJY, Yu J (2013) Genome-wide identification of Epstein-Barr virus\u2013driven promoter methylation profiles of human genes in gastric cancer cells. Cancer 119:304\u2013312. https:\/\/doi.org\/10.1002\/cncr.27724","journal-title":"Cancer"},{"key":"303_CR192","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/jmv.24863","volume":"89","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Liu W, Liu J, Wang J, Luo B (2017) The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. J Med Virol 89:1844\u20131851. https:\/\/doi.org\/10.1002\/jmv.24863","journal-title":"J Med Virol"},{"key":"303_CR193","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28338","volume":"95","author":"M-H Zhao","year":"2023","unstructured":"Zhao M-H, Liu W, Zhang X, Zhang Y, Luo B (2023) Epstein-Barr virus miR-BART2-5p and miR-BART11-5p regulate cell proliferation, apoptosis, and migration by targeting RB and p21 in gastric carcinoma. J Med Virol 95:e28338. https:\/\/doi.org\/10.1002\/jmv.28338","journal-title":"J Med Virol"},{"key":"303_CR194","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12250-017-3996-5","volume":"32","author":"L Zuo","year":"2017","unstructured":"Zuo L, Yue W, Du S, Xin S, Zhang J, Liu L, Li G, Lu J (2017) An update: Epstein-Barr virus and immune evasion via microRNA regulation. Virol Sin 32:175\u2013187. https:\/\/doi.org\/10.1007\/s12250-017-3996-5","journal-title":"Virol Sin"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T08:51:56Z","timestamp":1748335916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":195,"URL":"https:\/\/doi.org\/10.1007\/82_2025_303","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"28 May 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}